InvestorsHub Logo

go avxl

04/24/24 11:45 AM

#457481 RE: Good Ole Bill #457480

no wonder SP drop

still no NDA but more 3-71 BS

LakeshoreLeo1953

04/24/24 11:47 AM

#457482 RE: Good Ole Bill #457480

Context is likely appropriate.

2014 A2-73

sumbuysumsell

04/24/24 11:53 AM

#457485 RE: Good Ole Bill #457480

Old news. This is included in the Clinical Trial website information. A P2 trial with 40 participants. IMO another trial that will last years and won't result in an approval. SNAFU.

https://classic.clinicaltrials.gov/ct2/show/NCT06245213

Sponsors and Collaborators
Anavex Life Sciences Corp.
COGNISION
Cognitive Research Corporation
Hassman Research Institute

nidan7500

04/24/24 11:57 AM

#457488 RE: Good Ole Bill #457480

Good Ole Bill

DANKE...looks like a positive move for all involved.

attilathehunt

04/24/24 11:58 AM

#457489 RE: Good Ole Bill #457480

Ol' Good! 3-71 to the rescue...How many years will this delay approval of something...

Its Deja Vu..This is like 2017 all over again with the PK and PD for AD....Wheee baby! We have come a long way....Or is it full circle jerk???

georgejjl

04/24/24 12:04 PM

#457491 RE: Good Ole Bill #457480

”…"We are thrilled to partner with Anavex in this very important trial," said Matt Bevin, CEO at Cognision. "Our advanced EEG/ERP technology will provide early insights on the neural response to ANAVEX®3-71 in individuals with schizophrenia, possibly paving the way for more effective and targeted therapeutic interventions for this very vulnerable population."…”



Good luck and GOD bless,

HMB2010

04/24/24 12:57 PM

#457498 RE: Good Ole Bill #457480

The COGNISION® System is also used by clinicians to evaluate patients suffering from Alzheimer's disease and concussion.

powerwalker

04/24/24 2:55 PM

#457520 RE: Good Ole Bill #457480

Good Ole Bill, Cognision is a member of the Anavex Consortium that includes Merck, Takeda, Lundbeck and Alkemes along with Sage Therapeutics and Cadent Therapeutics.

https://www.businesswire.com/news/home/20190320005368/en/Industry-Consortium-Launched-to-Qualify-Biomarkers-for-Schizophrenia-Drug-Development

IMO, good news as the Consortium is beginning to move.
Bullish
Bullish